Integra Lifesciences Holdings (IART) Short-term Investments (2012 - 2026)

Integra Lifesciences Holdings' Short-term Investments history runs 6 years deep, the most recent figure standing at $28.7 million for Q1 2026.

• In Q1 2026, Short-term Investments fell 16.08% year-over-year to $28.7 million; the TTM figure through Mar 2026 stood at $28.7 million (down 16.08% YoY), while the FY2025 annual figure was $28.7 million, up 5.55% from the prior year.
• Short-term Investments came in at $28.7 million for Q1 2026 at Integra Lifesciences Holdings, roughly flat from $28.7 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $81.7 million in Q2 2024 to a low of $27.2 million in Q4 2024.
• A 4-year average of $43.8 million and a median of $34.9 million in 2025 frame the typical range for Short-term Investments.
• On a YoY basis, Short-term Investments climbed as much as 5.55% in 2025 and fell as far as 56.31% in 2025.
• Integra Lifesciences Holdings' Short-term Investments stood at $32.7 million in 2023, then decreased by 16.84% to $27.2 million in 2024, then rose by 5.55% to $28.7 million in 2025, then changed by 0.0% to $28.7 million in 2026.
• According to Business Quant data, Short-term Investments over the past three periods registered $28.7 million, $28.7 million, and $35.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison